High levels of FANCI expression have been observed in NSCLC tumor tissues, and FANCI knockdown has been shown to inhibit cell proliferation, migration, invasion, cell cycle progression, and EMT in vitro and ex vivo [99]. This evidence concerns the gene FANCI and non-small cell lung carcinoma.